380 filings
Page 7 of 19
8-K
joeowllo
8 Jan 21
PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules
4:15pm
424B5
07e plpq99k
7 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
zkn9gpm d0g3
6 Jan 21
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
9:30am
8-K
46vov3 ml
22 Dec 20
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
4:15pm
424B5
4vj3oo1i
18 Dec 20
Prospectus supplement for primary offering
4:33pm
8-K
3n0ot
18 Dec 20
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
9:29am
424B5
ms29suxr5 jjcb7xl
14 Dec 20
Prospectus supplement for primary offering
2:30pm
8-K
r2jrj7vyeg40p2j
11 Dec 20
PAVmed Announces Registered Direct Offering of its Common Stock
10:26am
8-K
3kswt sh7bvipxhhv7
17 Nov 20
PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update
4:25pm
EFFECT
phvuvw bvz
18 Sep 20
Notice of effectiveness
12:15am
UPLOAD
304g6l5yzvnfwm
14 Sep 20
Letter from SEC
12:00am
CORRESP
2mdgw49w60bkeva3z
14 Sep 20
Correspondence with SEC
12:00am
S-8
0uq4049xwss48
1 Sep 20
Registration of securities for employees
4:42pm
8-K
xitgq1s7
18 Aug 20
PAVmed Reports Second Quarter 2020 Financial Results and Provides Business Update
4:25pm
D
l5ztfw iu8o0
11 Aug 20
$7.75M in debt / options / securities to be acquired, sold $7.75M, 1 investor
2:49pm
8-K
yafqnq6
6 Aug 20
Entry into a Material Definitive Agreement
9:27am
8-K
frwjs kczq97j1wkn
27 Jul 20
Departure of Directors or Certain Officers
9:32am